GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » Valuation Rank

RIV Capital (XCNQ:RIV) Valuation Rank


View and export this data going back to 2018. Start your Free Trial

What is RIV Capital Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

RIV Capital Valuation Rank Related Terms

Thank you for viewing the detailed overview of RIV Capital's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

RIV Capital (XCNQ:RIV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » Valuation Rank
Comparable Companies
NEOE:TILT XCNQ:MVMD XCNQ:BAMM TSXV:MPH TSX:XLY XCNQ:VIN XCNQ:PWR TSXV:SBBC XCNQ:CANN TSX:VPH ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
CNPOF:USA
Address
40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2
Website
https://www.rivcapital.com
RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.